Latest news
Why Is CSL Limited (ASX:CSL) Drawing Market Attention? - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 05:47:00 GMTWhy Could CSL (ASX:CSL) Worth Watching Now? - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 04:10:00 GMTCSL share price: why investors like healthcare shares - Rask MediaRask Media · Sun, 09 Aug 2026 23:41:37 GMTCSL shares are rising: 3 things investors need to watch - The Motley Fool AustraliaThe Motley Fool Australia · Sun, 09 Aug 2026 23:20:06 GMTWhy Is CSL Limited (ASX:CSL) Back in the Biopharma Spotlight? - Kalkine MediaKalkine Media · Fri, 07 Aug 2026 04:05:00 GMTCSL Says European Commission Revokes Marketing Authorization for Tavneos - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 00:25:17 GMTCSL Confirms Lapse of 37,550 Conditional Rights Securities - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 23:14:00 GMTCSL : European Commission (EC) adopts decision to revoke marketing authorisation for TAVNEOS® (avacopan) in the European Union and European Economic Area countries - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 06:22:11 GMT